Epigenetic alterations in epstein-barr virus-associated diseases

Hans Helmut Niller, Ferenc Banati, D. Salamon, J. Mináróvits

Research output: Chapter in Book/Report/Conference proceedingChapter

12 Citations (Scopus)

Abstract

Latent Epstein-Bar virus genomes undergo epigenetic modifi cations which are dependent on the respective tissue type and cellular phenotype. These defi ne distinct viral epigenotypes corresponding with latent viral gene expression profi les. Viral Latent Membrane Proteins 1 and 2A can induce cellular DNA methyltransferases, thereby infl uencing the methylation status of the viral and cellular genomes. Therefore, not only the viral genomes carry epigenetic modifi cations, but also the cellular genomes adopt major epigenetic alterations upon EBV infection. The distinct cellular epigenotypes of EBV-infected cells differ from the epigenotypes of their normal counterparts. In Burkitt lymphoma (BL), nasopharyngeal carcinoma (NPC) and EBV-associated gastric carcinoma (EBVaGC) signify cant changes in the host cell methylome with a strong tendency towards CpG island hypermethylation are observed. Hypermethylated genes unique for EBVaGC suggest the existence of an EBV-specifi c “epigenetic signature”. Contrary to the primary malignancies carrying latent EBV genomes, lymphoblastoid cells (LCs) established by EBV infection of peripheral B cells in vitro are characterized by a massive genome-wide demethylation and a signifi cant decrease and redistribution of heterochromatic histone marks. Establishing complete epigenomes of the diverse EBV-associated malignancies shall clarify their similarities and differences and further clarify the contribution of EBV to the pathogenesis, especially for the epithelial malignancies, NPC and EBVaGC.

Original languageEnglish
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages39-69
Number of pages31
Volume879
DOIs
Publication statusPublished - 2016

Publication series

NameAdvances in Experimental Medicine and Biology
Volume879
ISSN (Print)00652598
ISSN (Electronic)22148019

Fingerprint

Virus Diseases
Human Herpesvirus 4
Viruses
Epigenomics
Genes
Genome
Stomach
Epstein-Barr Virus Infections
Viral Genome
Carcinoma
Cations
Histone Code
Viral Matrix Proteins
CpG Islands
Methylation
Neoplasms
Methyltransferases
Burkitt Lymphoma
Viral Genes
Gene expression

Keywords

  • Epigenetic signature
  • Genome-wide demethylation
  • Heterochromatic histone marks
  • Host cell methylome
  • Viral epigenotypes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Niller, H. H., Banati, F., Salamon, D., & Mináróvits, J. (2016). Epigenetic alterations in epstein-barr virus-associated diseases. In Advances in Experimental Medicine and Biology (Vol. 879, pp. 39-69). (Advances in Experimental Medicine and Biology; Vol. 879). Springer New York LLC. https://doi.org/10.1007/978-3-319-24738-0_3

Epigenetic alterations in epstein-barr virus-associated diseases. / Niller, Hans Helmut; Banati, Ferenc; Salamon, D.; Mináróvits, J.

Advances in Experimental Medicine and Biology. Vol. 879 Springer New York LLC, 2016. p. 39-69 (Advances in Experimental Medicine and Biology; Vol. 879).

Research output: Chapter in Book/Report/Conference proceedingChapter

Niller, HH, Banati, F, Salamon, D & Mináróvits, J 2016, Epigenetic alterations in epstein-barr virus-associated diseases. in Advances in Experimental Medicine and Biology. vol. 879, Advances in Experimental Medicine and Biology, vol. 879, Springer New York LLC, pp. 39-69. https://doi.org/10.1007/978-3-319-24738-0_3
Niller HH, Banati F, Salamon D, Mináróvits J. Epigenetic alterations in epstein-barr virus-associated diseases. In Advances in Experimental Medicine and Biology. Vol. 879. Springer New York LLC. 2016. p. 39-69. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-3-319-24738-0_3
Niller, Hans Helmut ; Banati, Ferenc ; Salamon, D. ; Mináróvits, J. / Epigenetic alterations in epstein-barr virus-associated diseases. Advances in Experimental Medicine and Biology. Vol. 879 Springer New York LLC, 2016. pp. 39-69 (Advances in Experimental Medicine and Biology).
@inbook{b02cf4a29fca44baa8ece7ac5c7c36d2,
title = "Epigenetic alterations in epstein-barr virus-associated diseases",
abstract = "Latent Epstein-Bar virus genomes undergo epigenetic modifi cations which are dependent on the respective tissue type and cellular phenotype. These defi ne distinct viral epigenotypes corresponding with latent viral gene expression profi les. Viral Latent Membrane Proteins 1 and 2A can induce cellular DNA methyltransferases, thereby infl uencing the methylation status of the viral and cellular genomes. Therefore, not only the viral genomes carry epigenetic modifi cations, but also the cellular genomes adopt major epigenetic alterations upon EBV infection. The distinct cellular epigenotypes of EBV-infected cells differ from the epigenotypes of their normal counterparts. In Burkitt lymphoma (BL), nasopharyngeal carcinoma (NPC) and EBV-associated gastric carcinoma (EBVaGC) signify cant changes in the host cell methylome with a strong tendency towards CpG island hypermethylation are observed. Hypermethylated genes unique for EBVaGC suggest the existence of an EBV-specifi c “epigenetic signature”. Contrary to the primary malignancies carrying latent EBV genomes, lymphoblastoid cells (LCs) established by EBV infection of peripheral B cells in vitro are characterized by a massive genome-wide demethylation and a signifi cant decrease and redistribution of heterochromatic histone marks. Establishing complete epigenomes of the diverse EBV-associated malignancies shall clarify their similarities and differences and further clarify the contribution of EBV to the pathogenesis, especially for the epithelial malignancies, NPC and EBVaGC.",
keywords = "Epigenetic signature, Genome-wide demethylation, Heterochromatic histone marks, Host cell methylome, Viral epigenotypes",
author = "Niller, {Hans Helmut} and Ferenc Banati and D. Salamon and J. Min{\'a}r{\'o}vits",
year = "2016",
doi = "10.1007/978-3-319-24738-0_3",
language = "English",
volume = "879",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "39--69",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - Epigenetic alterations in epstein-barr virus-associated diseases

AU - Niller, Hans Helmut

AU - Banati, Ferenc

AU - Salamon, D.

AU - Mináróvits, J.

PY - 2016

Y1 - 2016

N2 - Latent Epstein-Bar virus genomes undergo epigenetic modifi cations which are dependent on the respective tissue type and cellular phenotype. These defi ne distinct viral epigenotypes corresponding with latent viral gene expression profi les. Viral Latent Membrane Proteins 1 and 2A can induce cellular DNA methyltransferases, thereby infl uencing the methylation status of the viral and cellular genomes. Therefore, not only the viral genomes carry epigenetic modifi cations, but also the cellular genomes adopt major epigenetic alterations upon EBV infection. The distinct cellular epigenotypes of EBV-infected cells differ from the epigenotypes of their normal counterparts. In Burkitt lymphoma (BL), nasopharyngeal carcinoma (NPC) and EBV-associated gastric carcinoma (EBVaGC) signify cant changes in the host cell methylome with a strong tendency towards CpG island hypermethylation are observed. Hypermethylated genes unique for EBVaGC suggest the existence of an EBV-specifi c “epigenetic signature”. Contrary to the primary malignancies carrying latent EBV genomes, lymphoblastoid cells (LCs) established by EBV infection of peripheral B cells in vitro are characterized by a massive genome-wide demethylation and a signifi cant decrease and redistribution of heterochromatic histone marks. Establishing complete epigenomes of the diverse EBV-associated malignancies shall clarify their similarities and differences and further clarify the contribution of EBV to the pathogenesis, especially for the epithelial malignancies, NPC and EBVaGC.

AB - Latent Epstein-Bar virus genomes undergo epigenetic modifi cations which are dependent on the respective tissue type and cellular phenotype. These defi ne distinct viral epigenotypes corresponding with latent viral gene expression profi les. Viral Latent Membrane Proteins 1 and 2A can induce cellular DNA methyltransferases, thereby infl uencing the methylation status of the viral and cellular genomes. Therefore, not only the viral genomes carry epigenetic modifi cations, but also the cellular genomes adopt major epigenetic alterations upon EBV infection. The distinct cellular epigenotypes of EBV-infected cells differ from the epigenotypes of their normal counterparts. In Burkitt lymphoma (BL), nasopharyngeal carcinoma (NPC) and EBV-associated gastric carcinoma (EBVaGC) signify cant changes in the host cell methylome with a strong tendency towards CpG island hypermethylation are observed. Hypermethylated genes unique for EBVaGC suggest the existence of an EBV-specifi c “epigenetic signature”. Contrary to the primary malignancies carrying latent EBV genomes, lymphoblastoid cells (LCs) established by EBV infection of peripheral B cells in vitro are characterized by a massive genome-wide demethylation and a signifi cant decrease and redistribution of heterochromatic histone marks. Establishing complete epigenomes of the diverse EBV-associated malignancies shall clarify their similarities and differences and further clarify the contribution of EBV to the pathogenesis, especially for the epithelial malignancies, NPC and EBVaGC.

KW - Epigenetic signature

KW - Genome-wide demethylation

KW - Heterochromatic histone marks

KW - Host cell methylome

KW - Viral epigenotypes

UR - http://www.scopus.com/inward/record.url?scp=84949800275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949800275&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-24738-0_3

DO - 10.1007/978-3-319-24738-0_3

M3 - Chapter

VL - 879

T3 - Advances in Experimental Medicine and Biology

SP - 39

EP - 69

BT - Advances in Experimental Medicine and Biology

PB - Springer New York LLC

ER -